Ally Olotu

In the News

Charity walk: More midwives for safe delivery

AMREF and partners will host a charity walk to raise funds for a campaign dubbed, “More Midwifes for Safe Delivery”. The 4-km charity walk will be at the Green Grounds …

Update: Projects on diseases transmitted from animals to people

Update: Two projects investigating diseases transmitted from animals to people IHI CED Dr. Honorati Masanja (left) briefs high profile delegates before he officially opened the meeting in Bagamoyo on Monday. …

Recent Projects

Understanding and enhancing approaches to quality improvement in small and medium sized private facilities in sub-Saharan Africa

This is an evaluation study that IHI is conducting in collaboration with London school of hygiene and tropical medicine. The research takes place in the context of an innovative intervention …

Vaccine Delivery Costing Study

As countries drive towards achieving high and equitable coverage of life-saving vaccines, the availability of sustainable, equitable, and predictable financing for vaccine delivery is essential. Over the last two decades, …

Ally Olotu

Research Scientist & Clinician

Dr Ally Olotu is research physician with expertise in malaria epidemiology and clinical trials addressing malaria interventions such as malaria vaccines. After 2 years of clinical practice at Aga Khan Hospital in Dar es salaam, Tanzania he worked as a research clinician within several clinical studies of malaria pathogenesis at KEMRI-Wellcome Trust, Kenya. In 2005, he was awarded a WHO/TDR Career Development Fellowship in malaria vaccine development and spent a year at GSK Biologicals in Rixensart, Belgium and WHO/TDR headquarters in Geneva, Switzerland where he received training in training in malaria vaccine research and development and clinical trials management. He was also involved in coordinating two malaria vaccine trials in West Africa and played a role in the development of clinical trial protocols and standard operating procedures. He was a Co-PI in a multi-centre trial evaluating the safety and efficacy of RTS,S/AS01, a candidate malaria vaccine, and participated in setting up a clinical trial facility which provided support to the trial.  After the end of the industry-sponsored study, and under the supervision of Dr Philip Bejon, He initiated an investigator-led extension which formed the basis of his DPhil work which started in 2010 and ended in 2014. In 2015, He joined the Ifakara Health Institute where he was assigned to supervise the Equatorial Guinea Malaria Vaccine Initiative research project in Malabo, Bioko Island. Over the last 2 years, and working with both the public and private partners, he participated in the development of the protocols and SOPs for a whole sporozoite vaccine trial and trained a clinical trial team which successfully implemented the first ever clinical trial in the history of Equatorial Guinea.  His main contribution has been on the investigation of the long-term efficacy of a candidate malaria vaccine (RTS,S/AS01) in young children living in a malaria endemic country. He has also described the interaction between the vaccine efficacy and malaria exposure. In addition he has studied immunological markers of vaccine efficacy and of naturally-acquired infection. His research to-date has led to several publication in peer reviewed journals. In 2013 he won the Oxford University Nuffield Department of Medicine Graduate Research Prize for his DPhil work. He is currently collaborating with Sanaria Inc, Medical Care Development International in Equatorial Guinea and Swiss Tropical Public Health Institute

View Dr. Olotu’s Research Interests and Publications

Projects

Evaluation of whole sporozoite vaccines for malaria elimination

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016